Similar articles

• Merck v. Integra: Supreme Court permits use of patented compounds to obtain Food and Drug Administration approvals.

  Manthei JR, Hathaway CR, Grant MA, Chung DD. Manthei JR, et al. Food Drug Law J. 2006;61(2):273-7. Food Drug Law J. 2006. PMID: 16903032 No abstract available.
• A nail in the coffin for DNA sequence patents?

  Yamanaka M. Yamanaka M. Nat Biotechnol. 2008 Oct;26(10):1085-6. doi: 10.1038/nbt1008-1085. Nat Biotechnol. 2008. PMID: 18846072 No abstract available.
• Proposed changes to patent code loom over biotech industry.

  Coombs A. Coombs A. Nat Biotechnol. 2007 Dec;25(12):1333-4. doi: 10.1038/nbt1207-1333. Nat Biotechnol. 2007. PMID: 18066010 No abstract available.
• A consideration of the patentability of enantiomers in the pharmaceutical industry in the United States.

  Miller CP, Ullrich JW. Miller CP, et al. Chirality. 2008 Jun;20(6):762-70. doi: 10.1002/chir.20520. Chirality. 2008. PMID: 18200591 Review.
• Emerging patent issues in genomic diagnostics.

  Barton JH. Barton JH. Nat Biotechnol. 2006 Aug;24(8):939-41. doi: 10.1038/nbt0806-939. Nat Biotechnol. 2006. PMID: 16900135 Review. No abstract available.